Feb 26, 2026 04:05PM
Feb 12, 2026 06:00PM
Feb 12, 2026 06:00PM
Dec 12, 2025 08:30AM
Dec 12, 2025 08:30AM
Nov 18, 2025 08:01AM
Nov 18, 2025 08:00AM Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
Oct 29, 2025 04:15PM
Sep 24, 2025 04:05PM
Sep 16, 2025 06:57AM
Sep 15, 2025 08:36AM
Sep 15, 2025 08:35AM
Sep 11, 2025 06:49AM
Sep 9, 2025 07:31AM Emergent BioSolutions gets $56 million U.S. contract for smallpox vaccine
Sep 9, 2025 07:30AM
Sep 3, 2025 06:49AM
Aug 29, 2025 08:05AM
Aug 21, 2025 08:45AM
Aug 6, 2025 04:15PM
Jul 28, 2025 08:50AM
Jul 2, 2025 04:05PM Emergent BioSolutions (EBS) Expands NARCANDirect to Offer KLOXXADO Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate
Jul 2, 2025 04:05PM
Jun 18, 2025 08:45AM
Jun 5, 2025 07:00AM
Jun 5, 2025 07:00AM
May 7, 2025 04:05PM
May 1, 2025 05:07PM
Mar 20, 2025 08:06AM Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Mar 13, 2025 08:29AM
Mar 10, 2025 09:15AM
Mar 10, 2025 09:14AM
Mar 3, 2025 04:23PM
Feb 7, 2025 08:06AM
Jan 21, 2025 06:45AM
Jan 16, 2025 08:00AM Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
Jan 14, 2025 07:31AM
Jan 14, 2025 07:30AM
Dec 16, 2024 08:00AM
Dec 16, 2024 08:00AM
Nov 6, 2024 04:54PM
Nov 6, 2024 04:49PM
Nov 6, 2024 04:05PM Emergent BioSolutions Reports Third Quarter 2024 Financial Results
Sep 26, 2024 08:05AM
Sep 26, 2024 08:05AM
Sep 25, 2024 07:07AM
Sep 25, 2024 07:07AM
Sep 25, 2024 07:07AM
Sep 12, 2024 08:31AM
Sep 12, 2024 08:30AM Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola
Sep 4, 2024 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All